INTERVIEW: ViroMed Seeks Partnerships With Active Role

South Korea’s ViroMed, a front runner in gene therapy involving naked plasmid DNA, is searching for global partners for its leading project VM202 but is apparently in no hurry to make a decision. In an exclusive interview, its founder and chief science officer tells PharmAsia News what sort of partnerships it is seeking and the goals it hopes to achieve in the coming years.